Cherubic Ventures Closes $68.88 Million Fund VI

Cherubic Ventures has closed its $68.88 million Fund VI, lifting assets under management across its six funds above $500 million. The early-stage venture firm will invest in AI-native companies across infrastructure, developer tools, enterprise software, healthcare, physical AI and robotics. Its early portfolio company Sudo AI has reached a valuation of nearly $2 billion two years after founding. Fund VI portfolio companies have already raised more than $500 million in subsequent funding.

Early Stage AI Investments

The fund continues Cherubic Ventures’ early-stage focus. In robotics, Sudo AI’s sudo R1 robotic system is trained through virtual simulation and can handle unfamiliar objects without real-world manipulation data. Cherubic Ventures was the company’s earliest institutional investor.

The firm is also an early investor in Entire, the developer platform founded by former GitHub CEO Thomas Dohmke. Entire raised US$60 million earlier this year, which the firm described as the largest seed round for a developer tools startup.

Matt Cheng, Founder & Solo GP at Cherubic Ventures, said:

“After ten years, I am more certain than ever about why I chose to invest at the earliest stages. Working alongside exceptional founders, finding a path through uncertainty, and ultimately changing an industry is what keeps driving me.”

Portfolio Across Sectors

Other Fund VI investments include AI-powered patent technology platform Patlytics, along with healthcare and drug development companies Max AI, Generation Lab and therapiAI.

Founded in 2015, Cherubic Ventures has invested in more than 200 companies globally. Earlier investments include Hims & Hers, Flexport, Calm, Paidy, 91APP and Astranis.

Beginning A Second Decade

Fund VI begins Cherubic Ventures’ second decade. The firm was among the first venture firms to use the solo GP model and has been the earliest institutional investor in dozens of companies that became unicorns.

Matt Cheng, Founder & Solo GP at Cherubic Ventures, said:

“The past ten years have made me more certain that believing in founders before the answers are clear, and backing them through uncertainty, is at the heart of early-stage investing. In the next decade, we will continue to 'Stay Early' and work with the most exceptional founders to build the future we want to see.”